Ad is loading...
JPIVX
Price
$33.89
Change
+$0.36 (+1.07%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

JPIVX vs VVIAX

Header iconJPIVX vs VVIAX Comparison
Open Charts JPIVX vs VVIAXBanner chart's image
JPMorgan U.S. Applied Data Sci Val I
Price$33.89
Change+$0.36 (+1.07%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JPIVX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPIVX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPIVX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. JPIVX (179M). VVIAX pays higher dividends than JPIVX: VVIAX (2.36) vs JPIVX (1.65). JPIVX was incepted earlier than VVIAX: JPIVX (22 years) vs VVIAX (24 years). JPIVX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than JPIVX: VVIAX (3000) vs JPIVX (1000000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. JPIVX (23.07). VVIAX return over 5 years is better than : 53.09 vs. JPIVX (13.32).
JPIVXVVIAXJPIVX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD22.21519.672113%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets179M184B0%
Annual Yield % from dividends1.652.3670%
Returns for 1 year23.0726.0988%
Returns for 3 years-8.8324.77-36%
Returns for 5 years13.3253.0925%
Returns for 10 years-0.17112.26-0%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics